133748-22-8

Basic information

• Product Name: 1-(2,4-DIMETHYL-PHENYL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID
• Synonyms: AKOS BB-6995;1-(2,4-DIMETHYL-PHENYL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID;3-pyrrolidinecarboxylic acid, 1-(2,4-dimethylphenyl)-5-oxo-;1-(2,4-dimethylphenyl)-5-keto-pyrrolidine-3-carboxylic acid;1-(2,4-dimethylphenyl)-5-oxo-3-pyrrolidinecarboxylic acid;BAS 03277349;Oprea1_150742;Oprea1_662899
• CAS NO: 133748-22-8
• Molecular Formula: C₁₃H₁₅NO₃
• Molecular Weight: 233.26
• Mol File: 133748-22-8.mol

Chemical Properties

• Boiling Point: 535.2°Cat760mmHg
• Flash Point: 277.5°C
• Appearance: /
• Density: g/cm³
• Vapor Pressure: 2.76E-12mmHg at 25°C
• PKA: 4.45±0.20(Predicted)
• CAS DataBase Reference: 1-(2,4-DIMETHYL-PHENYL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2,4-DIMETHYL-PHENYL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID(133748-22-8)
• EPA Substance Registry System: 1-(2,4-DIMETHYL-PHENYL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID(133748-22-8)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 133748-22-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research:
1-(2,4-DIMETHYL-PHENYL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID is used as a research compound for its pharmacological activities, contributing to the advancement of drug discovery and development. It aids in the design and optimization of lead compounds for various diseases and conditions, enhancing the potential for new therapeutic agents.
Used in Organic Synthesis:
In the field of organic synthesis, 1-(2,4-DIMETHYL-PHENYL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID is used as a key intermediate or building block in the synthesis of more complex organic molecules. Its unique structure and reactivity make it a valuable component in the creation of novel compounds with potential applications in various industries.
Used in Drug Design:
1-(2,4-DIMETHYL-PHENYL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID is employed as a structural element in drug design, where its properties can be leveraged to develop new pharmaceuticals with improved efficacy, selectivity, and safety profiles. Its incorporation into drug candidates can lead to the discovery of innovative treatments for a range of medical conditions.
Used in Lead Optimization:
In the process of lead optimization, 1-(2,4-DIMETHYL-PHENYL)-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID is utilized to refine and improve the properties of potential drug candidates. Its versatility allows for the fine-tuning of pharmacokinetic and pharmacodynamic properties, increasing the likelihood of successful drug development.

InChI:InChI=1/C13H15NO3/c1-8-3-4-11(9(2)5-8)14-7-10(13(16)17)6-12(14)15/h3-5,10H,6-7H2,1-2H3,(H,16,17)/p-1/t10-/m1/s1

Downstream Products

• 500017-00-5 4-(1H-benzoimidazol-2-yl)-1-(2,4-dimethyl-phenyl)-pyrrolidin-2-one 

Relevant articles and documents

Phenylcarboxylic acid derivatives having hetero ring

Phenylcarboxylic acid derivatives having a hetero ring in the substituent of the formula: STR1 wherein R1 is halogen, alkyl, cycloalkyl, hydroxy, alkoxy, phenoxy which has a substituent selected from halogen and alkyl, carboxyl, alkylsulfonyloxy, phenylsulfonyloxy optionally substituted by halogen, alkylsulfonyloxyalkoxy, amino, alkanoylamino, benzoylamino, alkenyloxy, phenylalkoxyalkoxy, hydroxyalkoxy, phenylalkoxy having optionally 1 to 3 substituents selected from halogen, alkyl and alkoxy, halogenoalkyl, cycloalkyloxy optionally substituted by hydroxy, alkoxy substituted by cycloalkyl having optionally hydroxy substituent, imidazolylalkyl or imidazolylalkoxy; k is 0 or 1 to 3; or (R1)k is alkylenedioxy; A is alkylene or alkylenoxy; l is 0 or 1; B is methylene or carbonyl; m is 0 or 1; D is alkylene; E is alkylene or alkenylene; n is 0 or 1; and R2 is hydrogen or alkyl, or a salt thereof, which have fatty acid synthesis-inhibitory activity, cholesterol synthesis-inhibitory activity and are useful as antilipidemic agent, prophylactic and treating agent of arteriosclerosis, prophylactic and treating agent of obesity, antidiabetics.